Gibofsky, A.
124  Ergebnisse:
Personensuche X
?
1

A Phase 2b randomized trial of lorecivivint, a novel intra-..:

Yazici, Y. ; McAlindon, T.E. ; Gibofsky, A....
Osteoarthritis and Cartilage.  29 (2021)  5 - p. 654-666 , 2021
 
?
 
?
3

Results from a 52-week randomized, double-blind, placebo-co..:

Yazici, Y. ; McAlindon, T.E. ; Gibofsky, A....
Osteoarthritis and Cartilage.  26 (2018)  - p. S293-S294 , 2018
 
?
4

Radiographic outcomes were concordant with outcome measures..:

Yazici, Y. ; McAlindon, T.E. ; Gibofsky, A....
Osteoarthritis and Cartilage.  26 (2018)  - p. S244-S245 , 2018
 
?
5

A novel Wnt pathway inhibitor, SM04690, for the treatment o..:

Yazici, Y. ; McAlindon, T.E. ; Fleischmann, R....
Osteoarthritis and Cartilage.  25 (2017)  10 - p. 1598-1606 , 2017
 
?
 
?
8

Low-dose SoluMatrix meloxicam results in clinically meaning..:

Altman, R. ; Hochberg, M. ; Kivitz, A....
Osteoarthritis and Cartilage.  24 (2016)  - p. S419-S420 , 2016
 
?
9

Low-dose solumatrix meloxicam demonstrates low systemic exp..:

Altman, R. ; Hochberg, M. ; Gibofsky, A...
Osteoarthritis and Cartilage.  23 (2015)  - p. A324-A325 , 2015
 
?
10

Solumatrix diclofenac safety in older patients with osteoar..:

Altman, R.D. ; Hochberg, M. ; Gibofsky, A...
Osteoarthritis and Cartilage.  23 (2015)  - p. A335-A336 , 2015
 
?
 
?
 
?
14

The times they are a changin':

Yazici, Y. ; Gibofsky, A.
Rheumatology.  52 (2012)  1 - p. 3-4 , 2012
 
?
 
1-15